Takip et
Hossam Kadry, Ph.D.
Hossam Kadry, Ph.D.
Pfizer
pfizer.com üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
H Kadry, B Noorani, L Cucullo
Fluids and Barriers of the CNS 17, 1-24, 2020
12302020
Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets
H Kadry, S Wadnap, C Xu, F Ahsan
European Journal of Pharmaceutical Sciences 135, 60-67, 2019
2912019
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption
H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan
International journal of pharmaceutics 544 (1), 285-296, 2018
1542018
Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
A Keshavarz, H Kadry, A Alobaida, F Ahsan
Expert opinion on drug delivery 17 (4), 439-461, 2020
442020
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
TA Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li, ...
Lab on a Chip 20 (18), 3334-3345, 2020
322020
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17 (1): 69
H Kadry, B Noorani, L Cucullo
BioMed Central Ltd. https://doi. org/10.1186/s12987-020-00230-3 17, 1-24, 2020
232020
Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects …
H Kadry, B Noorani, U Bickel, TJ Abbruscato, L Cucullo
Fluids and Barriers of the CNS 18 (1), 28, 2021
222021
Statistical optimization and validation of a novel ultra-performance liquid chromatography method for estimation of nintedanib in rat and human plasma
SK Shukla, H Kadry, JA Bhatt, R Elbatanony, F Ahsan, V Gupta
Bioanalysis 12 (3), 159-174, 2020
112020
Advanced microfluidic vascularized tissues as platform for the study of human diseases and drug development
B Noorani, L Cucullo, Y Ahn, H Kadry, A Bhalerao, S Raut, E Nozohouri, ...
Current Neuropharmacology 21 (3), 599-620, 2023
52023
Method for Investigating FibroblastDurotaxis
H Kadry, D Lagares, TA Al-Hilal
Myofibroblasts: Methods and Protocols, 227-236, 2021
42021
Evaluation of barrier integrity using a two-layered microfluidic device mimicking the blood-brain barrier
H Kadry, L Cucullo
Vascular hyperpermeability: methods and protocols, 77-88, 2023
32023
A modelling approach to compare ADC deconjugation and systemic elimination rates of individual drug-load species using native ADC LC-MS data from human plasma
SM Hengel, AR Topletz-Erickson, H Kadry, SC Alley
Xenobiotica 54 (8), 492-501, 2024
12024
Bioengineering approach for pulmonary drug delivery
A Keshavarz, H Kadry, A Alobaida, M Nurunnabi, TA Al-Hilal
Bioinspired and Biomimetic Materials for Drug Delivery, 241-276, 2021
12021
Formulation and Optimization of Vardenafil Hydrochloride Oral Disintegrating Tablets: Effect of Superdisintegrants
H Kadry, AA Zaky, AA Kassem
Al-Azhar Journal of Pharmaceutical Sciences 53 (1), 39-57, 2016
12016
Shukla-Nintedanib UPLC-Bioanalysis-2020. pdf
S Shukla, H Kadry, J A Bhatt, R Elbatanony, F Ahsan, V Gupta
Health Research Alliance, 2025
2025
On-Demand and Point-of-Care Printing of Tablets for Sustained Drug Delivery and Personalized Dosing
H Kadry, S Wadnap, T Al-Hilal, C Xu, F Ahsan
American Association of Pharmaceutical Sciences (AAPS), 2018
2018
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–16